BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8276539)

  • 1. Epidermal growth factor in gastric carcinoma as a risk factor of postoperative recurrence.
    Ichiyoshi Y; Tateishi M; Toda T; Minamizono Y; Nagasaki S; Yao T; Sugimachi K
    Int Surg; 1993; 78(3):196-9. PubMed ID: 8276539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.
    Kikuchi S; Sato M; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
    Anticancer Res; 2000; 20(5C):3695-700. PubMed ID: 11268441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of survival period for patients with postoperative recurrence after curative resection for advanced gastric carcinoma.
    Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Hepatogastroenterology; 2001; 48(37):290-3. PubMed ID: 11268988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between bFGF mRNA and MMP-9 mRNA expression in gastric carcinoma and their clinicopathological features as well as patients survival].
    Zhao ZS; Yao GY; Ru GQ; Ma J; Ruan J
    Zhonghua Wai Ke Za Zhi; 2005 Feb; 43(3):169-72. PubMed ID: 15842896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of lymph node metastasis by size of early gastric carcinoma.
    Otsuji E; Kuriu Y; Ichikawa D; Ochiai T; Okamoto K; Yamagishi H
    Hepatogastroenterology; 2007 Mar; 54(74):602-5. PubMed ID: 17523331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcome in early gastric cancer with lymph node metastasis.
    Hanazaki K; Wakabayashi M; Sodeyama H; Makiuchi A; Igarashi J; Yokoyama S; Sode Y; Kawamura N; Ohtsuka M; Miyazaki T
    Hepatogastroenterology; 1997; 44(15):907-11. PubMed ID: 9222713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical results of early gastric cancer and proposing a treatment strategy.
    Lo SS; Wu CW; Chen JH; Li AF; Hsieh MC; Shen KH; Lin HJ; Lui WY
    Ann Surg Oncol; 2007 Feb; 14(2):340-7. PubMed ID: 17094028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early gastric cancer: univariate and multivariate analysis for survival.
    Tuech JJ; Cervi C; Pessaux P; Villapadierna F; Bergamaschi R; Ronceray J; Arnaud JP
    Hepatogastroenterology; 1999; 46(30):3276-80. PubMed ID: 10626201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
    Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
    J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
    Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
    Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence in patients following curative resection of early gastric carcinoma.
    Wu B; Wu D; Wang M; Wang G
    J Surg Oncol; 2008 Nov; 98(6):411-4. PubMed ID: 18767119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.